Davis Polk advised European Biotech Acquisition Corp. on the deal while Cooley and Vischer represented Oculis. European Biotech Acquisition Corp. (EBAC), a SPAC, signed its $200 million...
European Biotech Acquisition’s $200 Million Combination With Oculis
ESR Group Limited’s HK$14 Billion Joint Venture with Chinachem Group
Mayer Brown advised ESR Group Limited on the joint venture with Chinachem, represented by Slaughter and May. Carey Olsen assisted the lenders on the BVI law...
Fernweh’s Controlling Interest Acquisition in AZZ
Cooley advised affiliates of Fernweh Group on the deal. Fernweh Group announced its definitive agreement with AZZ. On June 23, Fernweh and AZZ jointly announced their entry...
Boston Scientific’s $1.75 Billion Acquisition of Baylis Medical Company
Shearman & Sterling advised Boston Scientific Corporation on the acquisition of Baylis Medical Company, assisted by BCF Business Law, in collaboration with Cooley LLP (U.S. lead...
Exscientia’s $510.4 Million IPO
Cooley LLP advised Exscientia on the deal while Goodwin Procter represented Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, BofA Securities and Barclays Capital...